Octapharma Plasma Forced to Close Locations Due to Cyberattack

Octapharma Plasma, a key player in the biopharmaceutical industry specializing in the collection of plasma used to create life-saving medicines, has been hit by a severe cyberattack, leading to a temporary closure of all its centers.

Octapharma Plasma Inc., a significant player in the healthcare sector, is part of the Octapharma AG group, headquartered in Lachen, Switzerland. With a strong presence in the U.S., operating over a hundred collection centers, the company's closure has a far-reaching impact. It not only disrupts the company's operations but also affects the production of essential medical therapies that are crucial for patients worldwide.

The company, which operates numerous plasma collection facilities across the United States, announced the network issues affecting operations on its website and via social media platforms, emphasizing the ongoing efforts by its support teams to address the disruptions.

Although specifics of the attack—such as the exact timing, the nature of the malware used, or whether data was stolen—have not been disclosed, the impact was significant enough to halt all operations. The repeated messages across different platforms indicate that the company is still in the process of thoroughly assessing and mitigating the damages caused by the attack.

The company has apologized for the inconvenience caused by the closures and reassured the public and stakeholders that their top priority is resolving the network issues and safely resuming operations.

If you have used Octapharma Plasma's services in the past and the exchange involved you disclosing/sharing your personal and medical data, there's a chance that this data might have been exposed to cybercriminals, though not confirmed yet. Out of an abundance of caution, treat all incoming communications with elevated vigilance, and closely monitor activity on your accounts.